Transition probabilities of diabetic retinopathy and death in an Asian population with diabetes

IF 3.7 3区 医学 Q1 OPHTHALMOLOGY Asia-Pacific Journal of Ophthalmology Pub Date : 2024-05-01 DOI:10.1016/j.apjo.2024.100070
Sudarshan Seshasai , Feng He , Betty Lam , Haslina Hamzah , Ching-Yu Cheng , Jialiang Li , Tien Yin Wong , Gavin Siew Wei Tan , Charumathi Sabanayagam
{"title":"Transition probabilities of diabetic retinopathy and death in an Asian population with diabetes","authors":"Sudarshan Seshasai ,&nbsp;Feng He ,&nbsp;Betty Lam ,&nbsp;Haslina Hamzah ,&nbsp;Ching-Yu Cheng ,&nbsp;Jialiang Li ,&nbsp;Tien Yin Wong ,&nbsp;Gavin Siew Wei Tan ,&nbsp;Charumathi Sabanayagam","doi":"10.1016/j.apjo.2024.100070","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>To evaluate the dynamic transitions in diabetic retinopathy (DR) severity over time and associated risk factors in an Asian population with diabetes.</p></div><div><h3>Design</h3><p>Longitudinal cohort study</p></div><div><h3>Methods</h3><p>We analyzed data from 9481 adults in the Singapore Integrated Diabetic Retinopathy Screening Program (2010–2015) with linkage to death registry. A multistate Markov model adjusted for age, sex, systolic blood pressure (SBP), diabetes duration, HbA1c, and body mass index (BMI) was applied to estimate annual transition probabilities between four DR states (no, mild, moderate, and severe/proliferative) and death, and the mean sojourn time in each state.</p></div><div><h3>Results</h3><p>The median assessment interval was 12 months, with most patients having 3 assessments. Annual probabilities for DR progression (no-to-mild, mild-to-moderate and moderate-to-severe/proliferative) were 6.1 %, 7.0 % and 19.3 %, respectively; and for regression (mild-to-no, moderate-to-mild and severe-to-moderate) were 55.4 %, 17.3 % and 4.4 %, respectively. Annual mortality rates from each DR state were 1.2 %, 2.0 %, 18.7 %, and 30.0 %. The sojourn time in each state were 8.2, 0.8, 0.8 and 2.2 years. Higher HbA1c and SBP levels were associated with progression of no-mild and mild-moderate DR, and diabetes duration with no-to-mild and moderate-to-severe/proliferative DR. Lower HbA1c levels were associated with regression from mild-to-no and moderate-to-mild, and higher BMI with mild-to-no DR.</p></div><div><h3>Conclusions</h3><p>Our results suggest a prolonged duration (∼8 years) in developing mild DR, with faster transitions (within a year) from mild or moderate states. Moderate/above DR greatly increases the probability of progression and death as compared to mild DR/below. HbA1c was associated with both progression as well as regression.</p></div>","PeriodicalId":8594,"journal":{"name":"Asia-Pacific Journal of Ophthalmology","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2162098924000719/pdfft?md5=0263ffbc445267442e3c7663ae7a45f8&pid=1-s2.0-S2162098924000719-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia-Pacific Journal of Ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2162098924000719","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

To evaluate the dynamic transitions in diabetic retinopathy (DR) severity over time and associated risk factors in an Asian population with diabetes.

Design

Longitudinal cohort study

Methods

We analyzed data from 9481 adults in the Singapore Integrated Diabetic Retinopathy Screening Program (2010–2015) with linkage to death registry. A multistate Markov model adjusted for age, sex, systolic blood pressure (SBP), diabetes duration, HbA1c, and body mass index (BMI) was applied to estimate annual transition probabilities between four DR states (no, mild, moderate, and severe/proliferative) and death, and the mean sojourn time in each state.

Results

The median assessment interval was 12 months, with most patients having 3 assessments. Annual probabilities for DR progression (no-to-mild, mild-to-moderate and moderate-to-severe/proliferative) were 6.1 %, 7.0 % and 19.3 %, respectively; and for regression (mild-to-no, moderate-to-mild and severe-to-moderate) were 55.4 %, 17.3 % and 4.4 %, respectively. Annual mortality rates from each DR state were 1.2 %, 2.0 %, 18.7 %, and 30.0 %. The sojourn time in each state were 8.2, 0.8, 0.8 and 2.2 years. Higher HbA1c and SBP levels were associated with progression of no-mild and mild-moderate DR, and diabetes duration with no-to-mild and moderate-to-severe/proliferative DR. Lower HbA1c levels were associated with regression from mild-to-no and moderate-to-mild, and higher BMI with mild-to-no DR.

Conclusions

Our results suggest a prolonged duration (∼8 years) in developing mild DR, with faster transitions (within a year) from mild or moderate states. Moderate/above DR greatly increases the probability of progression and death as compared to mild DR/below. HbA1c was associated with both progression as well as regression.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
亚洲糖尿病患者糖尿病视网膜病变和死亡的转变概率。
目的:评估亚洲糖尿病患者糖尿病视网膜病变(DR)严重程度随时间的动态变化及相关风险因素:纵向队列研究 方法:我们分析了新加坡综合糖尿病视网膜病变筛查项目(2010-2015 年)中 9481 名成人的数据,并与死亡登记进行了链接。我们采用了一个多状态马尔可夫模型,并对年龄、性别、收缩压(SBP)、糖尿病病程、HbA1c 和体重指数(BMI)进行了调整,以估算四种 DR 状态(无、轻度、中度和重度/增殖性)与死亡之间的年度转换概率,以及在每种状态下的平均停留时间:评估间隔中位数为 12 个月,大多数患者接受过 3 次评估。DR进展(无至轻度、轻度至中度和中度至重度/增殖性)的年概率分别为6.1%、7.0%和19.3%;DR退化(轻度至无、中度至轻度和重度至中度)的年概率分别为55.4%、17.3%和4.4%。DR 各州的年死亡率分别为 1.2%、2.0%、18.7% 和 30.0%。在各州的停留时间分别为 8.2 年、0.8 年、0.8 年和 2.2 年。较高的 HbA1c 和 SBP 水平与非轻度和轻度-中度 DR 的进展有关,糖尿病持续时间与非轻度和中度-重度/增生性 DR 有关。较低的 HbA1c 水平与轻度至非轻度和中度至轻度 DR 的进展有关,较高的 BMI 与轻度至非轻度 DR 有关:我们的研究结果表明,轻度 DR 的发展持续时间较长(约 8 年),从轻度或中度状态过渡的速度较快(一年内)。与轻度 DR/轻度以下相比,中度 DR/中度以上大大增加了病情恶化和死亡的概率。HbA1c 既与病情进展有关,也与病情消退有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
8.10
自引率
18.20%
发文量
197
审稿时长
6 weeks
期刊介绍: The Asia-Pacific Journal of Ophthalmology, a bimonthly, peer-reviewed online scientific publication, is an official publication of the Asia-Pacific Academy of Ophthalmology (APAO), a supranational organization which is committed to research, training, learning, publication and knowledge and skill transfers in ophthalmology and visual sciences. The Asia-Pacific Journal of Ophthalmology welcomes review articles on currently hot topics, original, previously unpublished manuscripts describing clinical investigations, clinical observations and clinically relevant laboratory investigations, as well as .perspectives containing personal viewpoints on topics with broad interests. Editorials are published by invitation only. Case reports are generally not considered. The Asia-Pacific Journal of Ophthalmology covers 16 subspecialties and is freely circulated among individual members of the APAO’s member societies, which amounts to a potential readership of over 50,000.
期刊最新文献
Development and testing of Artificial Intelligence based mobile application to achieve cataract backlog-free status in Uttar Pradesh, India. Comment on “Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination” An unusual iris in Waardenburg syndrome Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives Diversity, equity and inclusion in curriculum vitae for medical and surgical specialty training college entrance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1